High uptake of postpartum hormonal contraception among HIV-1-seropositive women in Kenya.
OBJECTIVE
The objectives of this study were to determine patterns of contraceptive utilization among sexually active HIV-1-seropositive women postpartum and to identify correlates of hormonal contraception uptake.


OBJECTIVE
The goal of this study was to improve delivery of family planning services to HIV-1-infected women in resource-limited settings.


METHODS
HIV-1-infected pregnant women were followed prospectively in a perinatal HIV-1 transmission study. Participants were referred to local clinics for contraceptive counseling and management.


RESULTS
Among 319 HIV-1-infected women, median time to sexual activity postpartum was 2 months and 231 (72%) women used hormonal contraception for at least 2 months during follow-up, initiating use at approximately 3 months postpartum (range, 1-11 months). Overall, 101 (44%) used DMPA, 71 (31%) oral contraception, and 59 (25%) switched methods during follow-up. Partner notification, infant mortality, and condom use were similar between those using and not using contraception.


CONCLUSIONS
Using existing the healthcare infrastructure, it is possible to achieve high levels of postpartum hormonal contraceptive utilization among HIV-1-seropositive women.
Balkus
Jennifer
J
Department of Epidemiology, University of Washington, Seattle, Washington 98104, USA. jbalkus@u.washington.edu
Bosire
Rose
R
John-Stewart
Grace
G
Mbori-Ngacha
Dorothy
D
Schiff
Melissa A
MA
Wamalwa
Dalton
D
Gichuhi
Christine
C
Obimbo
Elizabeth
E
Wariua
Grace
G
Farquhar
Carey
C
D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D003268:Contraception Behavior / Q000706:statistics & numerical data*; D003278:Contraceptives, Oral, Hormonal / Q000008:administration & dosage*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D015497:HIV-1; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D007630:Kenya / Q000453:epidemiology; D049590:Postpartum Period; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D011446:Prospective Studies; D016387:Women's Health
D003278:Contraceptives, Oral, Hormonal